# Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects

> **NCT00983788** · PHASE2 · COMPLETED · sponsor: **Rigshospitalet, Denmark** · enrollment: 12 (actual)

## Conditions studied

- Carnitine Palmitoyltransferase II Deficiency
- Very Long Chain Acyl Coa Dehydrogenase Deficiency

## Interventions

- **DRUG:** Bezafibrate
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT00983788
- **Lead sponsor:** Rigshospitalet, Denmark
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10
- **Primary completion:** 2011-09
- **Final completion:** 2011-09
- **Target enrollment:** 12 (ACTUAL)
- **Last updated:** 2012-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00983788

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00983788, "Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT00983788. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*